We are live on ! Find out more
VIVE

VIVEVE MED INC
VIVE

Delisted

VIVE was delisted on the 18th of January, 2023.

Back to rankings

15 hedge funds and large institutions have $374K invested in VIVEVE MED INC in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less capital invested

Capital invested by funds: $413K → $374K (-$39K)

25% less funds holding

Funds holding: 20 → 15 (-5)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
15
Holders Change
-5
Holders Change %
-25%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.95K
2
Osaic Holdings
Osaic Holdings
Arizona
+$600

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$17K
2
VF
Virtu Financial
New York
-$15K
3
Millennium Management
Millennium Management
New York
-$11K
4
UBS Group
UBS Group
Switzerland
-$4.81K
5
TSS
Two Sigma Securities
New York
-$1.39K

VIVE Hedge Fund Activity: Q3 2022 in Review

15 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q3 2022, worth a combined $374K — down 9.4% from $413K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of VIVE and 0 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $1.95K. The largest seller was Citadel Advisors, exiting entirely with an estimated $17K sold.

  • 15 institutional investors held VIVEVE MED INC (VIVE) as of Q3 2022, down from 20 in Q2 2022.
  • Funds reported $374K of VIVEVE MED INC stock for Q3 2022, down 9.4% quarter-over-quarter.
  • 0 funds opened new VIVEVE MED INC positions in Q3 2022 and 4 closed out, a net change of -4 holders.
  • The largest VIVEVE MED INC buyer in Q3 2022 was Renaissance Technologies, an estimated $1.95K added.
  • The largest VIVEVE MED INC seller in Q3 2022 was Citadel Advisors, an estimated $17K sold.

Based on aggregated 13F filings for Q3 2022.